Mirtazapine
- Level
- Commodity
- Parent
- 51292900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292908This classification denotes an antidepressant agent with the molecular formula C17H19N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A051Q2099Q, chemically known as 1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine but generally known as mirtazapine, which bears US NIH Compound Identifier 4205. European Medicines Agency schedules Mirtazapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08996MIG. The term MIRTAZAPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules mirtazapine in its Anatomical Therapeutic Chemical (ATC) Classification. MIRTAZAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mirtazapine under HS 29335995 and SITC 51576. As of Q4 2014, MIRTAZAPINE remains the US FDA Preferred Term for this commodity. Mirtazapine bears US NLM identifiers UMLS ID C0049506 and NCI Concept Code C29265. SMILES: N12C(CN(CC1)C)c1c(Cc3c2nccc3)cccc1.
Same parent
Under 51292900 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.